U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7917179171Safety and Efficacy of Mirazid for Schistosomiasis TreatmentCompletedNo Results AvailableSchistosoma Hematobium Infection|Schistosomiasis MansoniDrug: Myrrhhttps://ClinicalTrials.gov/show/NCT01529710
7917279172Prospective Study of the Feedback From an Adherence Monitor on Asthma ControlRecruitingNo Results AvailableAsthmaBehavioral: Active Feedbackhttps://ClinicalTrials.gov/show/NCT01529697
7917379173A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the BodyCompletedNo Results AvailableAdvanced Solid Tumors|Pharmacokinetics of 14C-OSI-906Drug: radio-labeled OSI-906|Drug: OSI-906https://ClinicalTrials.gov/show/NCT01529684
7917479174A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The KneeCompletedNo Results AvailablePainDrug: PF-05089771|Drug: PF-05089771|Drug: PF-05089771|Drug: PF-05089771|Drug: PF-05089771https://ClinicalTrials.gov/show/NCT01529671
7917579175Renal Hypothermia During Partial NephrectomyRecruitingNo Results AvailableRenal Impairment|Kidney Diseases|Urologic Diseases|Cancer|Hypothermia|Kidney CancerProcedure: Renal hypothermiahttps://ClinicalTrials.gov/show/NCT01529658
7917679176Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 YearsCompletedHas ResultsPertussis|Whooping Cough|Tetanus|Lockjaw|DiphtheriaBiological: Acellular pertussis vaccine|Biological: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)|Biological: Licensed TdaP booster vaccine|Biological: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)|Other: Saline solutionhttps://ClinicalTrials.gov/show/NCT01529645
7917779177Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: QVA149|Drug: NVA237|Drug: QAB149|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01529632
7917879178Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase InhibitorsCompletedNo Results AvailableAlzheimer's DiseaseDrug: Rivastigmine transdermal patchhttps://ClinicalTrials.gov/show/NCT01529619
7917979179Cold Plasma for Dental Restoration and Caries PreventionCompletedNo Results AvailableDental Restoration|CariesOther: Composite restoration and tooth cleaning|Procedure: Plasma treatmenthttps://ClinicalTrials.gov/show/NCT01529606
7918079180Temsirolimus in Combination With Metformin in Patients With Advanced CancersRecruitingNo Results AvailableAdvanced CancersDrug: Temsirolimus|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT01529593
7918179181School-Age Children With Autism With Limited Expressive Language SkillsCompletedNo Results AvailableAutism Spectrum DisorderBehavioral: Non-Verbal School Aged Children with Autism (NVSACA) Interventionhttps://ClinicalTrials.gov/show/NCT01529580
7918279182Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel SyndromeCompletedNo Results AvailableIrritable Bowel SyndromeBehavioral: Cognitive Behavioral Therapy without exposure|Behavioral: Cognitive Behavioral Therapy with exposurehttps://ClinicalTrials.gov/show/NCT01529567
7918379183Controlled Level EVERolimus in Acute Coronary SyndromesRecruitingNo Results AvailableAcute Coronary SyndromesDrug: Everolimus|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01529554
7918479184Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin AloneCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Anagliptin|Drug: Sitagliptinhttps://ClinicalTrials.gov/show/NCT01529541
7918579185A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus PatientsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Anagliptin|Drug: Anagliptin|Drug: Placebo of Anagliptinhttps://ClinicalTrials.gov/show/NCT01529528
7918679186A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaCompletedHas ResultsSchizophreniaDrug: PP3M 175 mg eq.|Drug: PP3M 263 mg eq.|Drug: PP3M 350 mg eq.|Drug: PP3M 525 mg eq.|Drug: Placebo (20% Intralipid emulsion)https://ClinicalTrials.gov/show/NCT01529515
7918779187Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This SettingCompletedNo Results AvailableBlood Transfusion|Endothelial Physiopathology|Inflammation|Hemoglobins|Nitric OxideProcedure: Red blood Cells auto-transfusion|Procedure: Red blood Cells auto-transfusion|Drug: Inhaled Nitric Oxide (iNO) administrationhttps://ClinicalTrials.gov/show/NCT01529502
7918879188Effect of Two Physical Training Programs on Oxygen Uptake and Heart Rate On-kinetics in Patients COPDCompletedNo Results AvailableChronic Obstructive Pulmonary Disease|HealthyOther: Resisted/Aerobic physical training|Other: Interval physical training in elliptical equipament|Other: Interval physical training in elliptical equipament|Other: Resisted/Aerobic physical traininghttps://ClinicalTrials.gov/show/NCT01529489
7918979189Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAPCompletedNo Results AvailablePneumoniaDrug: Levofloxacin|Drug: Nemonoxacinhttps://ClinicalTrials.gov/show/NCT01529476
7919079190Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure PatientsCompletedNo Results AvailableCongestive Heart Failure|Systolic Dysfunctionhttps://ClinicalTrials.gov/show/NCT01529463
7919179191Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened InhibitorsTerminatedNo Results AvailableBasal Cell CarcinomaDrug: LDE225https://ClinicalTrials.gov/show/NCT01529450
7919279192Sublingual Immunotherapy Studies for Grass and Dust Mite AllergiesCompletedNo Results AvailableAllergies|Allergic Rhinitis|AsthmaDrug: sublingual immunotherapy|Drug: placebo sublingual immunotherapyhttps://ClinicalTrials.gov/show/NCT01529437
7919379193Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in HypertriglyceridemiaActive, not recruitingNo Results AvailableHypertriglyceridemiaDrug: ISIS apoC-III Rx|Drug: ISIS apoC-III Rx|Drug: ISIS apoC-III Rx|Drug: Placebo|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01529424
7919479194Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial CancerCompletedNo Results AvailableCarcinoma, Transitional CellDrug: Vinflunine|Other: Undefined (standard care)https://ClinicalTrials.gov/show/NCT01529411
7919579195Sensorimotor Training Versus Resistance Training in Patients With Knee OsteoarthritisCompletedNo Results AvailableKnee OsteoarthritisOther: Sensorimotor training (SMT)|Other: Resistance training (RT)|Other: Control group (CG)https://ClinicalTrials.gov/show/NCT01529398
7919679196Mild Compression Sock for Control of Lower Extremity Edema in Individuals With DiabetesCompletedNo Results AvailableMild to Moderate Edema of Diabetic LegsDevice: mild compression diabetic sock|Device: Standard diabetic sockhttps://ClinicalTrials.gov/show/NCT01529385
7919779197REnAL denervatIon by ultraSound Transcatheter EmissionActive, not recruitingNo Results AvailableResistant HypertensionDevice: PARADISE percutaneous renal denervationhttps://ClinicalTrials.gov/show/NCT01529372
7919879198Irritable Bowel Syndrome and Lactibiane ToleranceRecruitingNo Results AvailableIrritable Bowel SyndromeDietary Supplement: Lactibiane Tolerance|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01529359
7919979199Efficacy Of PF-05089771 In Treating Postoperative Dental PainCompletedNo Results AvailablePostoperative Dental PainDrug: PF-05089771|Other: Placebo|Drug: PF-05089771|Other: Placebo|Drug: PF-05089771|Other: Placebo|Drug: Ibuprofen|Other: Placebo|Other: Placebo|Other: Placebohttps://ClinicalTrials.gov/show/NCT01529346
7920079200Middle-Ear Implant With MET V Transducer (Aka MET V System)Not yet recruitingNo Results AvailableMixed Conductive and Sensorineural Hearing Loss, BilateralDevice: Middle Ear Implant with MET V Transducerhttps://ClinicalTrials.gov/show/NCT01529333

* Görseller ve İçerik tekif hakkına sahip olabilir